The putative role of lutein and zeaxanthin as protective agents against age-related macular degeneration: Promise of molecular genetics for guiding mechanistic and translational research in the field

American Journal of Clinical Nutrition

Volumn 96, Issue 5, 2012, Pages

  SanGiovanni, John Paul ^a   Neuringer, Martha ^b  

^a NATIONAL EYE INSTITUTE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE P1; PLACEBO; XANTHOPHYLL; ZEAXANTHIN;

DRUG STRUCTURE; GENE EXPRESSION; HUMAN; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PHOTORECEPTOR; PIGMENT EPITHELIUM; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATIONAL RESEARCH; ULTRASTRUCTURE;

ANIMALS; HUMANS; LUTEIN; MACULAR DEGENERATION; RETINA; TRANSLATIONAL MEDICAL RESEARCH; XANTHOPHYLLS;

EID: 84867823018     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.038240     Document Type: Review

References (187)

1. Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vision Res 1985;25(11):1531-5. (Pubitemid 16207358)
2. Handelman GJ, Dratz EA, Reay CC, van Kuijk JG. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci 1988;29 (6):850-5.
3. Nussbaum JJ, Pruett RC, Delori FC. Historic perspectives. Macular yellow pigment. The first 200 years. Retina 1981;1(4):296-310.
4. Beatty S, Boulton M, Henson D, Koh HH, Murray IJ. Macular pigment and age related macular degeneration. British Journal of Ophthalmology 1999;83(7):867-77. (Pubitemid 29324801)
5. Whitehead AJ, Mares JA, Danis RP. Macular pigment: a review of current knowledge. Arch Ophthalmol 2006;124(7):1038-45. (Pubitemid 44036329)
6. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional manipulation of primate retinas, III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci 2005;46(2):692-702. (Pubitemid 40270354)
7. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J. Prevalence of agerelated macular degeneration in the United States. Arch Ophthalmol 2004;122(4):564-72. (Pubitemid 38456293)
8. Klein R, Chou CF, Klein BE, Zhang X, Meuer SM, Saaddine JB. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol 2011;129(1):75-80.
9. Congdon N, O'Colmain B, Klaver CCW, Klein R, Muoz B, Friedman D, Kempen J, Taylor H, Mitchell P. Causes and prevalence of visual impairment among adults in the United States. Archives of ophthalmology 2004;122(4):477-85. (Pubitemid 38456282)
10. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol 1992;110 (12):1701-8.
11. Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton TC, Farber MD, Gragoudas ES, Haller J, Miller DT, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. Journal of the American Medical Association 1994;272(18):1413-20. (Pubitemid 24328383)
12. Snellen EL, Verbeek AL, Van Den Hoogen GW, Cruysberg JR, Hoyng CB. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand 2002;80(4):368-71.
13. SanGiovanni JP, Chew EY, Clemons TE, Ferris FL, 3rd, Gensler G, Lindblad AS, Milton RC, Seddon JM, Sperduto RD. The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol 2007;125(9):1225-32. (Pubitemid 47403030)
14. Gale CR, Hall NF, Phillips DI, Martyn CN. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 2003;44(6):2461-5. (Pubitemid 36618402)
15. Delcourt C, Carriere I, Delage M, Barberger-Gateau P, Schalch W. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci 2006;47(6):2329-35. (Pubitemid 351639812)
16. Cho E, Hankinson SE, Rosner B, Willett WC, Colditz GA. Prospective study of lutein/zeaxanthin intake and risk of age-related macular degeneration. Am J Clin Nutr 2008;87(6):1837-43. (Pubitemid 351872649)
17. Tan JS,Wang JJ, Flood V, Rochtchina E, SmithW, Mitchell P. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology 2008;115 (2):334-41. (Pubitemid 351175680)
18. Bird AC. Therapeutic targets in age-related macular disease. J Clin Invest 2010;120(9):3033-41.
19. Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48(3):257-93. (Pubitemid 36553096)
20. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 2003;133(4):992-8. (Pubitemid 36407115)
21. Aleman TS, Cideciyan AV, Windsor EA, Schwartz SB, Swider M, Chico JD, Sumaroka A, Pantelyat AY, Duncan KG, Gardner LM, et al. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations. Invest Ophthalmol Vis Sci 2007;48(3):1319-29. (Pubitemid 351261430)
22. Malinow MR, Feeney-Burns L, Peterson LH, Klein ML, Neuringer M. Diet-related macular anomalies in monkeys. Invest Ophthalmol Vis Sci 1980;19(8):857-63. (Pubitemid 11041984)
23. Snodderly DM, Brown PK, Delori FC, Auran JD. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci 1984;25(6):660-73. (Pubitemid 14082976)
24. Snodderly DM, Auran JD, Delori FC. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci 1984;25(6):674-85. (Pubitemid 14082977)
25. Bone RA, Landrum JT, Fernandez L, Tarsis SL. Analysis of the macular pigment by HPLC: retinal distribution and age study. Invest Ophthalmol Vis Sci 1988;29(6):843-9.
26. Handelman GJ, Snodderly DM, Krinsky NI, Russett MD, Adler AJ. Biological control of primate macular pigment. Biochemical and densitometric studies. Invest Ophthalmol Vis Sci 1991;32(2): 257-67.
27. Bone RA, Landrum JT, Friedes LM, Gomez CM, Kilburn MD, Menendez E, Vidal I, Wang W. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res 1997;64(2): 211-8. (Pubitemid 27139567)
28. Khachik F, Bernstein PS, Garland DL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci 1997;38(9):1802-11. (Pubitemid 27382346)
29. Bernstein PS, Yoshida MD, Katz NB, McClane RW, Gellermann W. Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci 1998;39(11):2003-11. (Pubitemid 28455069)
30. Sommerburg OG, Siems WG, Hurst JS, Lewis JW, Kliger DS, van Kuijk FJ. Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr Eye Res 1999;19(6):491-5. (Pubitemid 30052875)
31. Rapp LM, Maple SS, Choi JH. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci 2000;41(5):1200-9. (Pubitemid 30187561)
32. Bernstein PS, Khachik F, Carvalho LS, Muir GJ, Zhao DY, Katz NB. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res 2001;72(3):215-23. (Pubitemid 32977974)
33. Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE. Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci 2001;42(1):235-40. (Pubitemid 32059436)
34. Bhosale P, Zhao da Y, Serban B, Bernstein PS. Identification of 3-methoxyzeaxanthin as a novel age-related carotenoid metabolite in the human macula. Invest Ophthalmol Vis Sci 2007;48(4):1435-40. (Pubitemid 351261322)
35. Bhosale P, Zhao da Y, Bernstein PS. HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era. Invest Ophthalmol Vis Sci 2007;48(2):543-9. (Pubitemid 351260683)
36. Mares-Perlman JA, Brady WE, Klein R, Klein BE, Bowen P, Stacewicz- Sapuntzakis M, Palta M. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol 1995;113(12):1518-23.
37. Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group. Arch Ophthalmol 1993;111 (1):104-9.
38. Bone RA, Landrum JT, Hime GW, Cains A, Zamor J. Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 1993;34 (6):2033-40. (Pubitemid 23148640)
39. The Gordon Research Conference on Carotenoids (http://www.grc.org/ conferences.aspx?id=0000309).
40. The International Carotenoid Society (http://www.carotenoidsociety.org/ meetings-and-conferences).
41. The Oxygen Club of California (http://www.oxyclubcalifornia.org/OCC/past- OCC-meetings.php).
42. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academy Press, 2000.
43. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 2003;23:171-201. (Pubitemid 37059721)
44. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys 2001;385(1):28-40. (Pubitemid 32988979)
45. Landrum JT, Bone RA, Kilburn MD. The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol 1997;38:537-56.
46. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45(2):115-34.
47. Schalch W, Dayhaw-Barker P, Barker II FM. The Carotenoids of the Human Retina. Edtion ed. In: Taylor A, ed. Nutritional and Environmental Influences on the Eye. Washington, D.C.: CRC Press, 1999:215-50.
48. Schalch W. Carotenoids in the retina-a review of their possible role in preventing or limiting damage caused by light and oxygen. Exs 1992; 62:280-98.
49. Snodderly DM. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 1995;62(6 Suppl):1448S-61S.
50. Mares-Perlman JA, Millen AE, Ficek TL, Hankinson SE. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic disease. Overview. J Nutr 2002;132(3):518S-24S. (Pubitemid 34208762)
51. Richer S, StilesW, Statkute L, Pulido J, Frankowski J, Rudy D, Pei K, Tsipursky M, Nyland J. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004;75(4):216-30. (Pubitemid 39208022)
52. Bartlett HE, Eperjesi F. Effect of lutein and antioxidant dietary supplementation on contrast sensitivity in age-related macular disease: a randomized controlled trial. Eur J Clin Nutr 2007;61(9):1121-7. (Pubitemid 47386599)
53. Neelam K, Hogg RE, Stevenson MR, Johnston E, Anderson R, Beatty S, Chakravarthy U. Carotenoids and co-antioxidants in age-related maculopathy: design and methods. Ophthalmic Epidemiol 2008;15 (6):389-401.
54. Bernstein PS, Delori FC, Richer S, van Kuijk FJ, Wenzel AJ. The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res 2010;50(7):716-28.
55. Li B, Vachali P, Bernstein PS. Human ocular carotenoid-binding proteins. Photochem Photobiol Sci 2010;9(11):1418-25.
56. Li B, Vachali P, Frederick JM, Bernstein PS. Identification of StARD3 as a Lutein-Binding Protein in the Macula of the Primate Retina. Biochemistry 2011;50(13):2541-9.
57. Bhosale P, Larson AJ, Frederick JM, Southwick K, Thulin CD, Bernstein PS. Identification and characterization of a Pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem 2004;279(47):49447-54. (Pubitemid 39625831)
58. Hammond BR, Jr., Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DM. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci 1997;38(9):1795-801. (Pubitemid 27382345)
59. Hammond BR, Jr., Wooten BR, Snodderly DM. Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis 1997;14(6):1187-96. (Pubitemid 127573887)
60. Zeimer M, Hense HW, Heimes B, Austermann U, Fobker M, Pauleikhoff D. [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study]. Ophthalmologe 2009;106(1):29-36.
61. Khachik F, Beecher GR, Goli MB, Lusby WR. Separation and quantitation of carotenoids in foods. Methods Enzymol 1992;213: 347-59. (Pubitemid 23012231)
62. Khachik F, Beecher GR, Goli MB, Lusby WR, Daitch CE. Separation and quantification of carotenoids in human plasma. Methods Enzymol 1992;213:205-19. (Pubitemid 23012217)
63. Khachik F, Spangler CJ, Smith JC, Jr., Canfield LM, Steck A, Pfander H. Identification, quantification, and relative concentrations of carotenoids and their metabolites in human milk and serum. Anal Chem 1997;69(10):1873-81.
64. Sommerburg O, Siems WG, van Kuijk FJ. Localization of carotenoids in different eye tissues. Biofactors 2000;11(1-2):3-6.
65. Subczynski WK, Wisniewska A, Widomska J. Location of macular xanthophylls in the most vulnerable regions of photoreceptor outersegment membranes. Arch Biochem Biophys 2010;504(1):61-6.
66. Beatty S, van Kuijk FJ, Chakravarthy U. Macular pigment and age-related macular degeneration: longitudinal data and better techniques of measurement are needed. Invest Ophthalmol Vis Sci 2008;49(3): 843-5.
67. Kaplan LA, Lau JM, Stein EA. Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem 1990;8(1):1-10. (Pubitemid 20094717)
68. Nolan JM, Stringham JM, Beatty S, Snodderly DM. Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci 2008;49(5):2134-42.
69. Delori FC, Goger DG, Keilhauer C, Salvetti P, Staurenghi G. Bimodal spatial distribution of macular pigment: evidence of a gender relationship. J Opt Soc Am A Opt Image Sci Vis 2006;23(3):521-38.
70. Berendschot TT, van Norren D. Macular pigment shows ring-like structures. Invest Ophthalmol Vis Sci 2006;47(2):709-14. (Pubitemid 46768401)
71. Werner JS, Donnelly SK, Kliegl R. Aging and human macular pigment density. Appended with translations from the work of Max Schultze and Ewald Hering. Vision Res 1987;27(2):257-68. (Pubitemid 17214269)
72. Pease PL, Adams AJ, Nuccio E. Optical density of human macular pigment. Vision Res 1987;27(5):705-10. (Pubitemid 17061899)
73. Hammond BR, Jr., Fuld K. Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci 1992;33(2):350-5.
74. Sharifzadeh M, Zhao DY, Bernstein PS, Gellermann W. Resonance Raman imaging of macular pigment distributions in the human retina. J Opt Soc Am A Opt Image Sci Vis 2008;25(4):947-57.
75. Sharifzadeh M, Bernstein PS, GellermannW. Nonmydriatic fluorescence-based quantitative imaging of human macular pigment distributions. J Opt Soc Am A Opt Image Sci Vis 2006;23(10):2373-87. (Pubitemid 44781639)
76. Demmig-Adams B, Adams WW, 3rd. Antioxidants in photosynthesis and human nutrition. Science 2002;298(5601):2149-53.
77. Wisniewska A, Subczynski WK. Distribution of macular xanthophylls between domains in a model of photoreceptor outer segment membranes. Free Radic Biol Med 2006;41(8):1257-65. (Pubitemid 44466321)
78. Boulton M, Rózanowska M, Rózanowski B. Retinal photo-damage. Journal of Photochemistry and Photobiology B: Biology 2001;64(2-3):144-61.
79. Ham WT, Jr., Mueller HA, Ruffolo JJ, Jr., Millen JE, Cleary SF, Guerry RK, Guerry D, 3rd. Basic mechanisms underlying the production of photochemical lesions in the mammalian retina. Curr Eye Res 1984;3(1):165-74. (Pubitemid 14163876)
80. Kim SR, Nakanishi K, Itagaki Y, Sparrow JR. Photooxidation of A2- PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp Eye Res 2006;82(5):828-39. (Pubitemid 43170883)
81. Sujak A, Gabrielska J, Grudzinski W, Borc R, Mazurek P, Gruszecki WI. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. Arch Biochem Biophys 1999;371(2):301-7.
82. Trevithick-Sutton CC, Foote CS, Collins M, Trevithick JR. The retinal carotenoids zeaxanthin and lutein scavenge superoxide and hydroxyl radicals: a chemiluminescence and ESR study. Mol Vis 2006;12: 1127-35. (Pubitemid 44480567)
83. Bhosale P, Bernstein PS. Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid membrane oxidation. Biochim Biophys Acta 2005;1740(2):116-21. (Pubitemid 40798220)
84. Wrona M, Rozanowska M, Sarna T. Zeaxanthin in combination with ascorbic acid or alpha-tocopherol protects ARPE-19 cells against photosensitized peroxidation of lipids. Free Radic Biol Med 2004;36 (9):1094-101. (Pubitemid 38479863)
85. Siems WG, Sommerburg O, van Kuijk FJ. Lycopene and betacarotene decompose more rapidly than lutein and zeaxanthin upon exposure to various pro-oxidants in vitro. Biofactors 1999;10(2-3):105-13. (Pubitemid 29533817)
86. Cantrell A, McGarvey DJ, Truscott TG, Rancan F, Bohm F. Singlet oxygen quenching by dietary carotenoids in a model membrane environment. Arch Biochem Biophys 2003;412(1):47-54. (Pubitemid 36324364)
87. Young AJ, Lowe GM. Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys 2001;385(1):20-7. (Pubitemid 32988978)
88. Krinsky NI, Yeum KJ. Carotenoid-radical interactions. Biochem Biophys Res Commun 2003;305(3):754-60. (Pubitemid 36579293)
89. Krinsky NI. Effects of carotenoids in cellular and animal systems. Am J Clin Nutr 1991;53(1 Suppl):238S-46S.
90. Krinsky NI. Mechanism of action of biological antioxidants. Proc Soc Exp Biol Med 1992;200(2):248-54.
91. Mein JR, Lian F, Wang XD. Biological activity of lycopene metabolites: implications for cancer prevention. Nutr Rev 2008;66(12):667-83.
92. Lian F, Smith DE, Ernst H, Russell RM, Wang XD. Apo-10′-lycopenoic acid inhibits lung cancer cell growth in vitro, and suppresses lung tumorigenesis in the A/J mouse model in vivo. Carcinogenesis 2007;28(7): 1567-74. (Pubitemid 47241807)
93. Prakash P, Liu C, Hu KQ, Krinsky NI, Russell RM, Wang XD. Beta-carotene and beta-apo-14′-carotenoic acid prevent the reduction of retinoic acid receptor beta in benzo[a]pyrene-treated normal human bronchial epithelial cells. J Nutr 2004;134(3):667-73. (Pubitemid 38298514)
94. Tibaduiza EC, Fleet JC, Russell RM, Krinsky NI. Excentric cleavage products of beta-carotene inhibit estrogen receptor positive and negative breast tumor cell growth in vitro and inhibit activator protein-1-mediated transcriptional activation. J Nutr 2002; 132(6):1368-75. (Pubitemid 34606478)
95. Ziouzenkova O, Orasanu G, Sukhova G, Lau E, Berger JP, Tang G, Krinsky NI, Dolnikowski GG, Plutzky J. Asymmetric cleavage of beta-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses. Mol Endocrinol 2007;21(1):77-88. (Pubitemid 46041692)
96. Zhang LX, Cooney RV, Bertram JS. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: relationship to their cancer chemopreventive action. Carcinogenesis 1991;12(11):2109-14.
97. Basu HN, Del Vecchio AJ, Flider F, Orfhoefer FT. Nutritional and potentential disease prevention properties of carotenoids. Journal of the American Oil Chemists Society 2001;78:665-75. (Pubitemid 32932251)
98. Dbouk HA, Mroue RM, El-Sabban ME, Talhouk RS. Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell Commun Signal 2009;7:4.
99. Bugos RC, Hieber AD, Yamamoto HY. Xanthophyll cycle enzymes are members of the lipocalin family, the first identified from plants. J Biol Chem 1998;273(25):15321-4. (Pubitemid 28298132)
100. Wenzel AJ, Sheehan JP, Burke JD, Lefsrud MG, Curran-Celentano J. Dietary intake and serum concentrations of lutein and zeaxanthin, but not macular pigment optical density, are related in spouses. Nutrition Research 2007;27(8):462-9. (Pubitemid 47126673)
101. Liew SH, Gilbert CE, Spector TD, Mellerio J, Marshall J, van Kuijk FJ, Beatty S, Fitzke F, Hammond CJ. Heritability of macular pigment: a twin study. Invest Ophthalmol Vis Sci 2005;46(12):4430-6. (Pubitemid 44264535)
102. Mares JA, LaRowe TL, Snodderly DM, Moeller SM, Gruber MJ, Klein ML,Wooten BR, Johnson EJ, Chappell RJ. Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Am J Clin Nutr 2006;84(5):1107-22. (Pubitemid 44730382)
103. Neuringer M, Sandstrom MM, Johnson EJ, Snodderly DM. Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys. Invest Ophthalmol Vis Sci 2004;45(9):3234-43. (Pubitemid 39121861)
104. Hammond BR, Jr., Curran-Celentano J, Judd S, Fuld K, Krinsky NI, Wooten BR, Snodderly DM. Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vision Res 1996;36(13):2001-12. (Pubitemid 26192671)
105. Carroll YL, Corridan BM, Morrissey PA. Carotenoids in young and elderly healthy humans: dietary intakes, biochemical status and diet-plasma relationships. Eur J Clin Nutr 1999;53(8):644-53. (Pubitemid 29396571)
106. Bone RA, Landrum JT, Dixon Z, Chen Y, Llerena CM. Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res 2000;71(3):239-45.
107. Brady WE, Mares-Perlman JA, Bowen P, Stacewicz-Sapuntzakis M. Human serum carotenoid concentrations are related to physiologic and lifestyle factors. J Nutr 1996;126(1):129-37. (Pubitemid 26030642)
108. Ciulla TA, Curran-Celantano J, Cooper DA, Hammond BR, Jr., Danis RP, Pratt LM, Riccardi KA, Filloon TG. Macular pigment optical density in a midwestern sample. Ophthalmology 2001;108(4):730-7. (Pubitemid 32238469)
109. Hammond BR, Jr., Ciulla TA, Snodderly DM. Macular pigment density is reduced in obese subjects. Invest Ophthalmol Vis Sci 2002; 43(1):47-50. (Pubitemid 34032439)
110. Nolan J, O'Donovan O, Kavanagh H, Stack J, Harrison M, Muldoon A, Mellerio J, Beatty S. Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci 2004;45(11):3940-50. (Pubitemid 39411145)
111. Rock CL, Thornquist MD, Neuhouser ML, Kristal AR, Neumark- Sztainer D, Cooper DA, Patterson RE, Cheskin LJ. Diet and lifestyle correlates of lutein in the blood and diet. J Nutr 2002;132(3):525S-30S. (Pubitemid 34208763)
112. Burke JD, Curran-Celentano J, Wenzel AJ. Diet and serum carotenoid concentrations affect macular pigment optical density in adults 45 years and older. J Nutr 2005;135(5):1208-14. (Pubitemid 40638329)
113. Rosenthal JM, Kim J, de Monasterio F, Thompson DJ, Bone RA, Landrum JT, de Moura FF, Khachik F, Chen H, Schleicher RL, et al. Dose-ranging study of lutein supplementation in persons aged 60 years or older. Invest Ophthalmol Vis Sci 2006;47(12):5227-33. (Pubitemid 46723769)
114. Huang LL, Coleman HR, Kim J, de Monasterio F, Wong WT, Schleicher RL, Ferris FL, 3rd, Chew EY. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD. Invest Ophthalmol Vis Sci 2008;49(9):3864-9.
115. Barker FM, 2nd, Snodderly DM, Johnson EJ, Schalch W, Koepcke W, Gerss J, Neuringer M. Nutritional Manipulation of Primate Retinas. V: Effects of Lutein, Zeaxanthin and n-3 Fatty Acids on Retinal Sensitivity to Blue Light Damage. Invest Ophthalmol Vis Sci 2011.
116. Swaroop A, Chew EY, Rickman CB, Abecasis GR. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet 2009;10:19-43.
117. Klein ML, Mauldin WM, Stoumbos VD. Heredity and age-related macular degeneration. Observations in monozygotic twins. Arch Ophthalmol 1994;112(7):932-7. (Pubitemid 24228253)
118. Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol 2005;123(3):321-7. (Pubitemid 41007575)
119. Heiba IM, Elston RC, Klein BE, Klein R. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol 1994;11(1):51-67. (Pubitemid 24089911)
120. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol 1997;123(2):199-206. (Pubitemid 27066775)
121. Klaver CC, Wolfs RC, Assink JJ, van Duijn CM, Hofman A, de Jong PT. Genetic risk of age-related maculopathy. Population-based familial aggregation study. Arch Ophthalmol 1998;116(12):1646-51. (Pubitemid 29001964)
122. Ho L, van Leeuwen R, Witteman JC, van Duijn CM, Uitterlinden AG, Hofman A, de Jong PT, Vingerling JR, Klaver CC. Reducing the genetic risk of age-related macular degeneration with dietary antioxidants, zinc, and omega-3 fatty acids: the Rotterdam study. Arch Ophthalmol 2011;129(6):758-66.
123. Loane E, Nolan JM, McKay GJ, Beatty S. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype. Exp Eye Res 2011.
124. Connor WE, Duell PB, Kean R, Wang Y. The prime role of HDL to transport lutein into the retina: evidence from HDL-deficient WHAM chicks having a mutant ABCA1 transporter. Invest Ophthalmol Vis Sci 2007;48(9):4226-31. (Pubitemid 351261053)
125. Tserentsoodol N, Gordiyenko NV, Pascual I, Lee JW, Fliesler SJ, Rodriguez IR. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol Vis 2006;12:1319-33. (Pubitemid 44688463)
126. During A, Doraiswamy S, Harrison EH. Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells via a SRBI-dependent mechanism. J Lipid Res 2008;49(8):1715-24.
127. Borel P, de Edelenyi FS, Vincent-Baudry S, Malezet-Desmoulin C, Margotat A, Lyan B, Gorrand JM, Meunier N, Drouault-Holowacz S, Bieuvelet S. Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans. Ann Med 2011;43(1):47-59.
128. Houssier M, Raoul W, Lavalette S, Keller N, Guillonneau X, Baragatti B, Jonet L, Jeanny JC, Behar-Cohen F, Coceani F, et al. CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents. PLoS Med 2008;5(2):e39.
129. Sun M, Finnemann SC, Febbraio M, Shan L, Annangudi SP, Podrez EA, Hoppe G, Darrow R, Organisciak DT, Salomon RG, et al. Light-induced oxidation of photoreceptor outer segment phospholipids generates ligands for CD36-mediated phagocytosis by retinal pigment epithelium: a potential mechanism for modulating outer segment phagocytosis under oxidant stress conditions. J Biol Chem 2006;281 (7):4222-30. doi: 10.1074/jbc.M509769200. (Pubitemid 43847851)
130. Picard E, Houssier M, Bujold K, Sapieha P, Lubell W, Dorfman A, Racine J, Hardy P, Febbraio M, Lachapelle P, et al. CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits. Aging (Albany NY) 2010;2(12):981-9.
131. Kondo N, Honda S, Kuno S, Negi A. Positive association of common variants in CD36 with neovascular age-related macular degeneration. Aging (Albany NY) 2009;1(2):266-74.
132. Voolstra O, Kiefer C, Hoehne M, Welsch R, Vogt K, von Lintig J. The Drosophila class B scavenger receptor NinaD-I is a cell surface receptor mediating carotenoid transport for visual chromophore synthesis. Biochemistry 2006;45(45):13429-37. (Pubitemid 44748489)
133. Kiefer C, Sumser E, Wernet MF, Von Lintig J. A class B scavenger receptor mediates the cellular uptake of carotenoids in Drosophila. Proc Natl Acad Sci U S A 2002;99(16):10581-6.
134. Giovannucci DR, Stephenson RS. Identification and distribution of dietary precursors of the Drosophila visual pigment chromophore: analysis of carotenoids in wild type and ninaD mutants by HPLC. Vision Res 1999;39(2):219-29. (Pubitemid 29052370)
135. Constantineau J, Greason E, West M, Filbin M, Kieft JS, Carletti MZ, Christenson LK, Rodriguez A. A synonymous variant in scavenger receptor, class B, type I gene is associated with lower SR-BI protein expression and function. Atherosclerosis 2010;210(1):177-82.
136. Provost AC, Vede L, Bigot K, Keller N, Tailleux A, Jais JP, Savoldelli M, Ameqrane I, Lacassagne E, Legeais JM, et al. Morphologic and electroretinographic phenotype of SR-BI knockout mice after a long-term atherogenic diet. Invest Ophthalmol Vis Sci 2009;50(8): 3931-42.
137. Zerbib J, Seddon JM, Richard F, Reynolds R, Leveziel N, Benlian P, Borel P, Feingold J, Munnich A, Soubrane G, et al. rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One 2009;4(10):e7341.
138. Bernstein PS, Balashov NA, Tsong ED, Rando RR. Retinal tubulin binds macular carotenoids. Invest Ophthalmol Vis Sci 1997;38(1): 167-75. (Pubitemid 27051535)
139. Crabtree DV, Ojima I, Geng X, Adler AJ. Tubulins in the primate retina: evidence that xanthophylls may be endogenous ligands for the paclitaxel-binding site. Bioorg Med Chem 2001;9(8):1967-76.
140. Yemelyanov AY, Katz NB, Bernstein PS. Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res 2001;72(4):381-92. (Pubitemid 32977233)
141. Machalinska A, Klos P, Safranow K, Dziedziejko V, Rudnicki M, Paczkowska E, Karczewicz D, Machalinski B. Neural stem/progenitor cells circulating in peripheral blood of patients with neovascular form of AMD: a novel view on pathophysiology. Graefes Arch Clin Exp Ophthalmol 2011.
142. Anderson DH, Ozaki S, Nealon M, Neitz J, Mullins RF, Hageman GS, Johnson LV. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol 2001;131(6):767-81. (Pubitemid 32522648)
143. Fernandez-Robredo P, Recalde S, Arnaiz G, Salinas-Alaman A, Sadaba LM, Moreno-Orduna M, Garcia-Layana A. Effect of zeaxanthin and antioxidant supplementation on vascular endothelial growth factor (VEGF) expression in apolipoprotein-E deficient mice. Curr Eye Res 2009;34(7):543-52.
144. Loane E, Nolan JM, Beatty S. The respective relationships between lipoprotein profile, macular pigment optical density, and serum concentrations of lutein and zeaxanthin. Invest Ophthalmol Vis Sci 2010; 51(11):5897-905.
145. Loane E, McKay GJ, Nolan JM, Beatty S. Apolipoprotein E genotype is associated with macular pigment optical density. Invest Ophthalmol Vis Sci 2010;51(5):2636-43.
146. Souied EH, Benlian P, Amouyel P, Feingold J, Lagarde JP, Munnich A, Kaplan J, Coscas G, Soubrane G. The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative agerelated macular degeneration. Am J Ophthalmol 1998;125(3):353-9. (Pubitemid 28124364)
147. Klaver CC, Kliffen M, van Duijn CM, Hofman A, Cruts M, Grobbee DE, van Broeckhoven C, de Jong PT. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet 1998;63(1):200-6. (Pubitemid 30428336)
148. Zareparsi S, Reddick AC, Branham KE, Moore KB, Jessup L, Thoms S, Smith-Wheelock M, Yashar BM, Swaroop A. Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. Invest Ophthalmol Vis Sci 2004;45(5):1306-10. (Pubitemid 38859304)
149. Baird PN, Guida E, Chu DT, Vu HT, Guymer RH. The epsilon2 and epsilon4 alleles of the apolipoprotein gene are associated with agerelated macular degeneration. Invest Ophthalmol Vis Sci 2004;45(5): 1311-5. (Pubitemid 38859305)
150. Francis PJ, Hamon SC, Ott J, Weleber RG, Klein ML. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. J Med Genet 2009;46(5):300-7.
151. Tikellis G, Sun C, Gorin MB, Klein R, Klein BE, Larsen EK, Siscovick DS, Hubbard LD, Wong TY. Apolipoprotein e gene and agerelated maculopathy in older individuals: the cardiovascular health study. Arch Ophthalmol 2007;125(1):68-73. (Pubitemid 46072378)
152. Wong TY, Shankar A, Klein R, Bray MS, Couper DJ, Klein BE, Sharrett AR, Folsom AR. Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study. Ophthalmology 2006;113(2):255-9. (Pubitemid 43170774)
153. Zareparsi S, Buraczynska M, Branham KE, Shah S, Eng D, Li M, Pawar H, Yashar BM, Moroi SE, Lichter PR, et al. Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. Hum Mol Genet 2005;14(11):1449-55. (Pubitemid 40834203)
154. McKay GJ, Patterson CC, Chakravarthy U, Dasari S, Klaver CC, Vingerling JR, Ho L, de Jong PT, Fletcher AE, Young IS, et al. Evidence of association of APOE with age-related macular degeneration - a pooled analysis of 15 studies. Hum Mutat 2011.
155. Duncan KG, Hosseini K, Bailey KR, Yang H, Lowe RJ, Matthes MT, Kane JP, LaVail MM, Schwartz DM, Duncan JL. Expression of reverse cholesterol transport proteins ATP-binding cassette A1 (ABCA1) and scavenger receptor BI (SR-BI) in the retina and retinal pigment epithelium. Br J Ophthalmol 2009;93(8):1116-20.
156. Yu Y, Reynolds R, Fagerness J, Rosner B, Daly MJ, Seddon JM. Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci 2011;52(7):4663-70.
157. Yu Y, Bhangale TR, Fagerness J, Ripke S, Thorleifsson G, Tan PL, Souied EH, Richardson AJ, Merriam JE, Buitendijk GH, et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet 2011;20(18):3699-709.
158. Fauser S, Smailhodzic D, Caramoy A, van de Ven JP, Kirchhof B, Hoyng CB, Klevering BJ, Liakopoulos S, den Hollander AI. Evaluation of Serum Lipid Concentrations and Genetic Variants at High- Density Lipoprotein Metabolism Loci and TIMP3 in Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci 2011;52(8): 5525-8.
159. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, Tan PL, Oh EC, Merriam JE, Souied E, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A 2010;107(16):7395-400.
160. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, Tosakulwong N, Pericak-Vance MA, Campochiaro PA, Klein ML, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A 2010;107(16): 7401-6.
161. Colak E, Kosanovic-Jakovic N, Zoric L, Radosavljevic A, Stankovic S, Majkic-Singh N. The association of lipoprotein parameters and Creactive protein in patients with age-related macular degeneration. Ophthalmic Res 2011;46(3):125-32.
162. Oz O, Aras Ates N, Tamer L, Yildirim O, Adiguzel U. Glutathione Stransferase M1, T1, and P1 gene polymorphism in exudative agerelated macular degeneration: a preliminary report. Eur J Ophthalmol 2006;16(1):105-10.
163. Guven M, Gorgun E, Unal M, Yenerel M, Batar B, Kucumen B, Dinc UA, Guven GS, Ulus T, Yuksel A. Glutathione S-transferase M1, GSTT1 and GSTP1 genetic polymorphisms and the risk of age-related macular degeneration. Ophthalmic Res 2011;46(1):31-7.
164. Lindqvist A, He YG, Andersson S. Cell type-specific expression of beta-carotene 9',10'-monooxygenase in human tissues. J Histochem Cytochem 2005;53(11):1403-12. (Pubitemid 41513072)
165. Ferrucci L, Perry JR, Matteini A, Perola M, Tanaka T, Silander K, Rice N, Melzer D, Murray A, Cluett C, et al. Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am J Hum Genet 2009;84(2):123-33.
166. Castaneda MP, Hirschler EM, Sams AR. Skin pigmentation evaluation in broilers fed natural and synthetic pigments. Poult Sci 2005;84 (1):143-7. (Pubitemid 40134377)
167. Eriksson J, Larson G, Gunnarsson U, Bed'hom B, Tixier-Boichard M, Stromstedt L, Wright D, Jungerius A, Vereijken A, Randi E, et al. Identification of the yellow skin gene reveals a hybrid origin of the domestic chicken. PLoS Genet 2008;4(2):e1000010.
168. Vage DI, Boman IA. A nonsense mutation in the beta-carotene oxygenase 2 (BCO2) gene is tightly associated with accumulation of carotenoids in adipose tissue in sheep (Ovis aries). BMC Genet 2010; 11:10.
169. Casaroli-Marano RP, Peinado-Onsurbe J, Reina M, Staels B, Auwerx J, Vilaro S. Lipoprotein lipase in highly vascularized structures of the eye. J Lipid Res 1996;37(5):1037-44. (Pubitemid 26182336)
170. Herbeth B, Gueguen S, Leroy P, Siest G, Visvikis-Siest S. The lipoprotein lipase serine 447 stop polymorphism is associated with altered serum carotenoid concentrations in the Stanislas Family Study. J Am Coll Nutr 2007;26(6):655-62.
171. Horie S, Okuda C, Yamashita T, Watanabe K, Kuramochi K, Hosokawa M, Takeuchi T, Kakuda M, Miyashita K, Sugawara F, et al. Purified canola lutein selectively inhibits specific isoforms of mammalian DNA polymerases and reduces inflammatory response. Lipids 2010; 45(8):713-21.
172. Kojima A, Nakahama K, Ohno-Matsui K, Shimada N, Mori K, Iseki S, Sato T, Mochizuki M, Morita I. Connexin 43 contributes to differentiation of retinal pigment epithelial cells via cyclic AMP signaling. Biochem Biophys Res Commun 2008;366(2):532-8. (Pubitemid 50010421)
173. Lambooij AC, van Wely KH, Lindenbergh-Kortleve DJ, Kuijpers RW, Kliffen M, Mooy CM. Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2003;44(5):2192-8. (Pubitemid 36520317)
174. Smith LE. IGF-1 and retinopathy of prematurity in the preterm infant. Biol Neonate 2005;88(3):237-44. (Pubitemid 41433556)
175. Whitmire W, Al-Gayyar MM, Abdelsaid M, Yousufzai BK, El-Remessy AB. Alteration of growth factors and neuronal death in diabetic retinopathy: what we have learned so far. Mol Vis 2011;17:300-8.
176. van der Veen RL, Fuijkschot J, Willemsen MA, Cruysberg JR, Berendschot TT, Theelen T. Patients with Sjogren-Larsson syndrome lack macular pigment. Ophthalmology 2010;117(5):966-71.
177. Molday LL, Rabin AR, Molday RS. ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy. Nat Genet 2000;25(3):257-8. (Pubitemid 30437308)
178. Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, Zabriskie NA, Li Y, Hutchinson A, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science 1997;277(5333):1805-7. (Pubitemid 27449189)
179. Rizzo WB, Carney G. Sjogren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Hum Mutat 2005;26(1):1-10. (Pubitemid 40983989)
180. Allikmets R, Seddon JM, Bernstein PS, Hutchinson A, Atkinson A, Sharma S, Gerrard B, Li W, Metzker ML, Wadelius C, et al. Evaluation of the Best disease gene in patients with age-related macular degeneration and other maculopathies. Hum Genet 1999;104(6):449-53. (Pubitemid 29370918)
181. Bernstein PS, Leppert M, Singh N, Dean M, Lewis RA, Lupski JR, Allikmets R, Seddon JM. Genotype-phenotype analysis of ABCR variants in macular degeneration probands and siblings. Invest Ophthalmol Vis Sci 2002;43(2):466-73. (Pubitemid 34113230)
182. De La Paz MA, Guy VK, Abou-Donia S, Heinis R, Bracken B, Vance JM, Gilbert JR, Gass JD, Haines JL, Pericak-Vance MA. Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. Ophthalmology 1999;106(8):1531-6. (Pubitemid 30214352)
183. Shroyer NF, Lewis RA, Allikmets R, Singh N, Dean M, Leppert M, Lupski JR. The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial. Vision Res 1999;39(15):2537-44. (Pubitemid 29197299)
184. Brion M, Sanchez-Salorio M, Corton M, de la Fuente M, Pazos B, Othman M, Swaroop A, Abecasis G, Sobrino B, Carracedo A. Genetic association study of age-related macular degeneration in the Spanish population. Acta Ophthalmol 2010;89(1):e12-22.
185. Cumming RC, Lightfoot J, Beard K, Youssoufian H, O'Brien PJ, Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 2001;7(7):814-20. (Pubitemid 32691636)
186. Reuter TY, Medhurst AL, Waisfisz Q, Zhi Y, Herterich S, Hoehn H, Gross HJ, Joenje H, Hoatlin ME, Mathew CG, et al. Yeast two-hybrid screens imply involvement of Fanconi anemia proteins in transcription regulation, cell signaling, oxidative metabolism, and cellular transport. Exp Cell Res 2003;289(2):211-21. (Pubitemid 37117407)
187. Zheng W, Reem RE, Omarova S, Huang S, Dipatre PL, Charvet CD, Curcio CA, Pikuleva IA. Spatial distribution of the pathways of cholesterol homeostasis in human retina. PLoS One 2012;7(5): e37926. doi: 10.1371/journal.pone.0037926.